Loading...

© 2026 MedXY

Contact us About us Privacy Policy MedXY story

MedXY News - cancer

MedXY AI/MedXY News/Tag: cancer

MedXY News

EnglishTag

cancer

22 all articles · 20 / page

Ask MedXY AI

type 2 diabetes clinical trial immunotherapy heart failure obesity atrial fibrillation cardiovascular risk Cardiology biomarkers clinical trials Hypertension oncology public health critical care artificial intelligence breast cancer Alzheimer's disease diabetes cardiovascular disease type 1 diabetes nutrition chronic kidney disease

Latest news

Tag

Cancer and Heart Failure in Scotland: Epidemiology, Interactions, and Prognostic Implications

Cancer and Heart Failure in Scotland: Epidemiology, Interactions, and Prognostic Implications

By MedXY|Jun 24, 2026

This review synthesizes evidence on the prevalence, incidence, and prognosis of cancer and heart failure comorbidity in Scotland, integrating recent cohort data and cardio-oncology research to inform clinical practice and future research di

Longitudinal Risk for Suicidal Self-Directed Violence Among Veterans With Cancer

Longitudinal Risk for Suicidal Self-Directed Violence Among Veterans With Cancer

By MedXY|May 31, 2026

A national study of veterans with cancer found elevated suicide-related risk that persisted for years, especially among younger, unmarried, frail, or mentally ill patients and those with certain cancers such as central nervous system and th

Inflammatory and Cardiac Biomarkers Predict VTE and Bleeding Risks in Cancer Patients

Inflammatory and Cardiac Biomarkers Predict VTE and Bleeding Risks in Cancer Patients

By MedXY|Apr 22, 2026

Elevated levels of inflammatory and cardiac biomarkers are linked to higher risks of venous thromboembolism and bleeding in cancer patients, according to a post hoc analysis of the AVERT trial.

The Changing Landscape of Mortality in Diabetes: A Shift from Cardiovascular Dominance to Cancer and Dementia

The Changing Landscape of Mortality in Diabetes: A Shift from Cardiovascular Dominance to Cancer and Dementia

By MedXY|Mar 15, 2026

This review analyzes multinational data showing a significant decline in cardiovascular mortality among diabetes patients, alongside a concerning rise in dementia-related deaths and the emergence of cancer as a leading cause of mortality in

Medical Cannabis as an Opioid-Sparing Strategy: Evidence from Chronic and Cancer Pain Populations

Medical Cannabis as an Opioid-Sparing Strategy: Evidence from Chronic and Cancer Pain Populations

By MedXY|Jan 1, 2026

This review synthesizes recent evidence from large-scale cohorts and synthetic control studies, demonstrating that medical cannabis participation and dispensary availability are significantly associated with reduced opioid prescriptions and

Acupuncture for Cancer-Related Insomnia: Limited, Low-Certainty Benefits Compared with Sham or No Treatment; Inferior to CBT‑I

Acupuncture for Cancer-Related Insomnia: Limited, Low-Certainty Benefits Compared with Sham or No Treatment; Inferior to CBT‑I

By MedXY|Dec 16, 2025

A 2025 Cochrane review (5 RCTs, 402 patients, mainly women with breast cancer) finds very low- to moderate-certainty evidence that acupuncture delivers small, uncertain sleep diary benefits versus sham or inactive controls and is probably l

Reduced Arsenic in Drinking Water Tied to Large Drops in Cancer and Cardiovascular Mortality

Reduced Arsenic in Drinking Water Tied to Large Drops in Cancer and Cardiovascular Mortality

By MedXY|Nov 17, 2025

A prospective cohort in Bangladesh found that declines in urinary arsenic were associated with substantially lower chronic-disease mortality—including cancer and cardiovascular deaths—supporting public-health efforts to reduce arsenic expos

Breaking the Immortality of Cancer Cells: Israel’s Groundbreaking RNA-Targeting Drug

Hematology-Oncology

Breaking the Immortality of Cancer Cells: Israel’s Groundbreaking RNA-Targeting Drug

By MedXY|Nov 10, 2025

Israeli scientists have developed a novel small molecule drug that targets RNA structures maintaining cancer cell immortality, providing a promising new approach to treating hard-to-cure cancers with unparalleled precision.

What patients and clinicians want to know next: UK–Ireland research priorities for oesophageal and stomach cancers

Gastroenterology

What patients and clinicians want to know next: UK–Ireland research priorities for oesophageal and stomach cancers

By MedXY|Nov 8, 2025

A UK–Ireland partnership ranked the top research uncertainties for oesophagogastric cancers; priorities emphasize personalising multimodal treatment, nutrition and quality of life, and stronger patient-centred trial design to accelerate mea

Impacts of Plant-Based Diets on Multimorbidity Risk in Cancer and Cardiometabolic Diseases Across Age Groups

Impacts of Plant-Based Diets on Multimorbidity Risk in Cancer and Cardiometabolic Diseases Across Age Groups

By MedXY|Oct 20, 2025

This analysis of EPIC and UK Biobank cohorts reveals that healthy plant-based diets reduce multimorbidity risk of cancer and cardiometabolic diseases, especially in middle-aged adults, underscoring diet’s role in chronic disease prevention

Why Do Chimpanzees Rarely Get Cancer? Unveiling a Key Evolutionary Difference That Could Revolutionize Immunotherapy

Allergy & Immunology

Why Do Chimpanzees Rarely Get Cancer? Unveiling a Key Evolutionary Difference That Could Revolutionize Immunotherapy

By MedXY|Oct 7, 2025

New research reveals that a protein called plasmin weakens human immune response against cancer compared to chimpanzees, offering promising strategies to enhance cancer immunotherapy.

Bridging the Gap: Addressing Inconsistent Reporting of Venous and Arterial Thrombotic Events in Cancer Clinical Trials

Clinical Updates

Bridging the Gap: Addressing Inconsistent Reporting of Venous and Arterial Thrombotic Events in Cancer Clinical Trials

By MedXY|Oct 6, 2025

Venous and arterial thrombotic events in cancer patients are underreported in clinical trials, impairing risk assessment and prevention strategies. Uniform and comprehensive reporting is imperative to improve patient outcomes and guide ther

The Hidden Risks of Alcohol: How Drinking Raises the Risk of 61 Diseases in Men—and Why Quitting Matters

The Hidden Risks of Alcohol: How Drinking Raises the Risk of 61 Diseases in Men—and Why Quitting Matters

By MedXY|Aug 26, 2025

Emerging research reveals that any alcohol consumption increases the risk of dozens of diseases, debunking myths about moderate drinking’s benefits—especially for Chinese men. Quitting alcohol triggers remarkable health improvements and red

Extended Rivaroxaban Therapy in Cancer Patients with Low-Risk Pulmonary Embolism: 6 OR 18 Months？

Extended Rivaroxaban Therapy in Cancer Patients with Low-Risk Pulmonary Embolism: 6 OR 18 Months？

By MedXY|Oct 5, 2025

An 18-month course of rivaroxaban significantly lowers recurrent venous thromboembolism compared to 6 months in cancer patients with low-risk pulmonary embolism without a substantial increase in major bleeding risk.

Evaluating the Adjuvant Role of Low-Dose Aspirin in Cancer-Associated Venous Thromboembolism: Efficacy, Safety, and Clinical Implications

Evaluating the Adjuvant Role of Low-Dose Aspirin in Cancer-Associated Venous Thromboembolism: Efficacy, Safety, and Clinical Implications

By MedXY|Oct 4, 2025

Low-dose aspirin added to anticoagulation for cancer-associated VTE reduces recurrence and PE-related mortality but increases bleeding risk, without improving overall survival or net clinical benefit over 6 months.

Emerging Roles of Circular RNAs in Cancer and Immunotherapy: Mechanisms and Clinical Potential

Allergy & Immunology

Emerging Roles of Circular RNAs in Cancer and Immunotherapy: Mechanisms and Clinical Potential

By MedXY|Oct 4, 2025

Circular RNAs (circRNAs) are pivotal regulators in cancer biology and immunotherapy, acting through mechanisms such as miRNA sponging, protein interactions, and translation. Their modulation of tumor immune microenvironment offers promising

Revolutionizing Cancer Therapy: Synergistic Action of Two Natural Bacteria in Complete Tumor Eradication

Clinical Updates

Revolutionizing Cancer Therapy: Synergistic Action of Two Natural Bacteria in Complete Tumor Eradication

By MedXY|Oct 1, 2025

A novel bacteria-based therapy using two natural strains demonstrates complete tumor clearance in immunocompromised models, offering hope for cancer patients unsuitable for current immunotherapies.

Pickled Delights: Delicious but Potentially Dangerous?

Family Medicine & Nutrition

Pickled Delights: Delicious but Potentially Dangerous?

By MedXY|Oct 1, 2025

Explore the beloved tradition of pickled foods, their health impacts, and safer consumption tips.

Overcoming PD-1 Inhibitor Resistance: Six Emerging Strategies from the 2025 ASCO Annual Meeting

Clinical Updates

Overcoming PD-1 Inhibitor Resistance: Six Emerging Strategies from the 2025 ASCO Annual Meeting

By MedXY|Oct 1, 2025

PD-1 inhibitor resistance is a major hurdle in cancer immunotherapy. Six leading combination strategies—including chemotherapy, anti-angiogenic agents, radiotherapy, novel checkpoint inhibitors, microbiome modulation, and ADCs—offer new hop

Unveiling the Hidden Dangers: How Dining Habits Can Impact Your Health

Family Medicine & Nutrition

Unveiling the Hidden Dangers: How Dining Habits Can Impact Your Health

By MedXY|Dec 25, 2025

Explore how everyday dining habits can lead to health risks, including cancer, and learn preventive measures.

Ask MedXY AI

Most popular

Clinical Updates

Retatrutide in Type 2 Diabetes and MASLD: Integrative Evidence on Body Composition and Liver Fat Reduction

Family Medicine & Nutrition

The Curious Scent of Feces: The Dual Identity and Health Secrets of Skatole

Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization: Bridging the Gap Between Prescription and Sustained Use

Family Medicine & Nutrition

How Often Should Men Have Sex? Harvard Study Links 21 Times a Month to Lower Prostate Cancer Risk

ACOG Endorses Updated 2026 Cervical Cancer Screening Guidelines: Key Changes and Implications